Publication | Open Access
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
10.9K
Citations
12
References
2004
Year
The addition of bevacizumab to fluorouracil-based combination chemotherapy results in statistically significant and clinically meaningful improvement in survival among patients with metastatic colorectal cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1